These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 2598331
1. Enhancement of the dissolution rates of poorly water-soluble drugs by water-soluble gelatin. Imai T, Nishiyama T, Ueno M, Otagiri M. Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2251-2. PubMed ID: 2598331 [Abstract] [Full Text] [Related]
2. Improved dissolution and absorption of drugs using low molecular gelatin. Kimura S, Nishiyama T, Imai T, Otagiri M. Acta Pharm Nord; 1990 Aug; 2(2):65-72. PubMed ID: 2354031 [Abstract] [Full Text] [Related]
3. Rapidly absorbed solid oral formulations of ibuprofen using water-soluble gelatin. Imai T, Kimura S, Iijima T, Miyoshi T, Ueno M, Otagiri M. J Pharm Pharmacol; 1990 Sep; 42(9):615-9. PubMed ID: 1981899 [Abstract] [Full Text] [Related]
4. Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs. Imai T, Nishiyama T, Shameem M, Otagiri M. Pharm Dev Technol; 1998 May; 3(2):225-32. PubMed ID: 9653760 [Abstract] [Full Text] [Related]
5. Enhancement of the dissolution rate and gastrointestinal absorption of pranlukast as a model poorly water-soluble drug by grinding with gelatin. Chono S, Takeda E, Seki T, Morimoto K. Int J Pharm; 2008 Jan 22; 347(1-2):71-8. PubMed ID: 17689212 [Abstract] [Full Text] [Related]
6. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs. Bazzo GC, Pezzini BR, Stulzer HK. Int J Pharm; 2020 Oct 15; 588():119741. PubMed ID: 32783978 [Abstract] [Full Text] [Related]
7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Eur J Pharm Biopharm; 2013 Nov 15; 85(3 Pt B):873-81. PubMed ID: 23537574 [Abstract] [Full Text] [Related]
8. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Yousaf AM, Kim DW, Oh YK, Yong CS, Kim JO, Choi HG. Int J Nanomedicine; 2015 Nov 15; 10():1819-30. PubMed ID: 25784807 [Abstract] [Full Text] [Related]
9. Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid/saccharin for improvement of wettability and dissolution rate. Hyun SM, Lee BJ, Abuzar SM, Lee S, Joo Y, Hong SH, Kang H, Kwon KA, Velaga S, Hwang SJ. Int J Pharm; 2019 Jan 10; 554():61-71. PubMed ID: 30347274 [Abstract] [Full Text] [Related]
10. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution. Tay T, Allahham A, Morton DA, Stewart PJ. J Pharm Sci; 2011 Oct 10; 100(10):4269-80. PubMed ID: 21560127 [Abstract] [Full Text] [Related]
11. Evaluation of low-molecular gelatin as a pharmaceutical additive for rapidly absorbed oral dosage formulation. Kimura S, Imai T, Otagiri M. Chem Pharm Bull (Tokyo); 1991 May 10; 39(5):1328-9. PubMed ID: 1914011 [Abstract] [Full Text] [Related]
12. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients. Widanapathirana L, Tale S, Reineke TM. Mol Pharm; 2015 Jul 06; 12(7):2537-43. PubMed ID: 26046484 [Abstract] [Full Text] [Related]
13. Transformation of acidic poorly water soluble drugs into ionic liquids. Balk A, Wiest J, Widmer T, Galli B, Holzgrabe U, Meinel L. Eur J Pharm Biopharm; 2015 Aug 06; 94():73-82. PubMed ID: 25976317 [Abstract] [Full Text] [Related]
14. Understanding the relationship between wettability and dissolution of solid dispersion. Lu Y, Tang N, Lian R, Qi J, Wu W. Int J Pharm; 2014 Apr 25; 465(1-2):25-31. PubMed ID: 24524825 [Abstract] [Full Text] [Related]
15. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives. Tay T, Allahham A, Morton DA, Stewart PJ. Eur J Pharm Biopharm; 2011 Nov 25; 79(3):674-82. PubMed ID: 21703348 [Abstract] [Full Text] [Related]
16. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Vogt M, Kunath K, Dressman JB. Eur J Pharm Biopharm; 2008 Feb 25; 68(2):330-7. PubMed ID: 17574401 [Abstract] [Full Text] [Related]
17. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution. Moribe K, Makishima T, Higashi K, Liu N, Limwikrant W, Ding W, Masuda M, Shimizu T, Yamamoto K. Int J Pharm; 2014 Jul 20; 469(1):190-6. PubMed ID: 24746412 [Abstract] [Full Text] [Related]
18. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans. Anraku M, Arahira M, Mady FM, Khaled KA, Yamasaki K, Seo H, Imai T, Otagiri M. Pharmazie; 2010 Jul 20; 65(7):461-6. PubMed ID: 20662311 [Abstract] [Full Text] [Related]
19. Dissolution rate enhancement of piroxicam by ordered mixing. Saharan VA, Choudhury PK. Pak J Pharm Sci; 2012 Jul 20; 25(3):521-33. PubMed ID: 22713937 [Abstract] [Full Text] [Related]
20. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates. Tran CTM, Tran PHL, Tran TTD. Drug Dev Ind Pharm; 2019 Mar 20; 45(3):514-519. PubMed ID: 30575412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]